CIPLA DONEPEZIL donepezil hydrochloride (as monohydrate) 10 mg film-coated tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

donepezil hydrochloride monohydrate, Quantity: 10.43 mg (Equivalent: donepezil hydrochloride, Qty 10 mg)

Commercializzato da:

Cipla Australia Pty Ltd

INN (Nome Internazionale):

donepezil hydrochloride monohydrate

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: magnesium stearate; croscarmellose sodium; lactose monohydrate; maize starch; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000

Via di somministrazione:

Oral

Confezione:

7 tablets, 14 tablets, 28 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

CIPLA DONEPEZIL (donepezil hydrochloride) is indicated for the treatment of mild, moderate and severe Alzheimer's disease.

Dettagli prodotto:

Visual Identification: Yellow coloured circular, biconvex film-coated tablets with "10" debossed on one side and "DPZ" debossed on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-12-18